A letter to to the New York Times was published yesterday, from AdvaMed Spokesperson, Christopher L. White. In it, White establishes support for the Physician Payment Sunshine Act, saying it "complements our code of ethics."
The editorial comes in response to several opinion pieces published over the last few weeks, since CMS issued its draft guidance:
I see Stossel's point. The Sunshine Act will provide fodder for lawyers, and line some undeserving pockets. I find it a bit overblown to conclude that critics are deliberately trying to make the medical device and pharmaceutical companies fail, especially after Obama's speech that called out advanced manufacturing as that lifeblood of the new economy.
I don't like fear tactics or "us vs. them" mentalities. However, I do appreciate the argument that begrudging a bagel in pursuit of a doctor's education is off the mark. I might, however, begrudge a week-long conference in Hawaii at a 5-star hotel.
Incidentally, White also explains that the association is developing its formal statement regarding the Act. While we wait, please sound off on our poll, Will the Sunshine Act help or hurt industry?: